MBOT
Microbot Medical Inc.
$2.13
+0.00%
2026-05-08
About Microbot Medical Inc.
Microbot Medical Inc. is a medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system designed to maneuver guidewires and over-the-wire devices such as microcatheters within the body's vasculature for use in cardiovascular, peripheral, endovascular, and neurovascular operations. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system; and Emory University, in connection with autonomous robotics in endovascular procedures. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts
Key Fundamentals
Forward P/E
-6.42
EPS (TTM)
$-0.29
ROE
-32.4%
Profit Margin
0.0%
Debt/Equity
1.11
Price/Book
1.84
Beta
1.06
Market Cap
$142.4M
Avg Volume (10D)
1.0M
Recent Breakout Signals
No recent breakout signals detected for MBOT.
Recent Price Range (60 Days)
60D High
$2.86
60D Low
$1.98
Avg Volume
1.7M
Latest Close
$2.13
Get breakout alerts for MBOT
Sign up for Breakout Scanner to receive daily notifications when MBOT triggers breakout signals. Build custom AI screeners and backtest strategies.
Start Free Trial7-day free trial. No card required.
Microbot Medical Inc. (MBOT) is listed on the NASDAQ (NASDAQ). Breakout Scanner monitors MBOT daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. MBOT operates in the Healthcare sector within the Medical Instruments & Supplies industry. Data is provided for informational purposes only and does not constitute financial advice.